Phoenix Biotech Acquisition Corp.
PBAXNASDAQFinancial Services
$5.85
+$0.37(+6.75%)
Market Cap$36472293
P/E Ratio—
52W High$12.8
52W Low$4.12
Phoenix Biotech Acquisition Corp. (PBAX) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PBAX · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Margin %(computed) | — | — | — | — |
| Operating Expenses | ||||
| R&D Expenses | $0.01B | $0.01B | $0.00B | $0.00B |
| G&A Expenses | $0.01B | $0.01B | $0.00B | $0.00B |
| Total Operating Expenses | $0.02B | $0.02B | $0.00B | $0.00B |
| Operating Income | ($0.02B) | ($0.02B) | ($0.00B) | ($0.00B) |
| Operating Margin %(computed) | — | — | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.10B) | ($0.01B) | ($0.00B) | ($0.00B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | ($0.00B) |
| Net Income | ($0.10B) | ($0.01B) | ($0.00B) | ($0.00B) |
| Net Margin %(computed) | — | — | — | — |
| Per Share & EBITDA | ||||
| EPS (Basic) | $-22.58 | $-0.22 | $-0.01 | $-0.00 |
| Wtd Avg Shares | 0.00B | 0.05B | 0.07B | 0.07B |
| EBITDA | ($0.02B) | ($0.02B) | ($0.01B) | ($0.00B) |
| EBITDA Margin %(computed) | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more Phoenix Biotech Acquisition Corp. data
About Phoenix Biotech Acquisition Corp. (PBAX) Income Statement
Phoenix Biotech Acquisition Corp. (PBAX) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, PBAX reported revenue of $0.00B, gross profit of $0.00B (gross margin —), and net income of ($0.10B) — a net profit margin of —.
Frequently asked questions
PBAX · 4 questionsPhoenix Biotech Acquisition Corp. (PBAX) reported revenue of $0.00B for 2025, down —% year-over-year.
PBAX revenuePBAX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09